LON:GNS Genus (GNS) Share Price, News & Analysis GBX 1,710 -36.00 (-2.06%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range 1,696▼ 1,79450-Day Range 1,630▼ 1,90452-Week Range 1,478▼ 2,378Volume66,403 shsAverage Volume111,683 shsMarket Capitalization£1.13 billionP/E Ratio3,352.94Dividend Yield1.87%Price TargetGBX 2,150 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades Get Genus alerts: Email Address Genus MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside25.7% UpsideGBX 2,150 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.98Based on 9 Articles This WeekInsider TradingAcquiring Shares£5.40 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.51 out of 5 stars 3.5 Analyst's Opinion Consensus RatingGenus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageGenus has only been the subject of 1 research reports in the past 90 days.Read more about Genus' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for GNS. Previous Next 0.8 Dividend Strength Dividend YieldGenus pays a meaningful dividend of 1.78%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGenus does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Genus is 6,274.51%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Genus' dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GNS. Previous Next 2.8 News and Social Media Coverage News SentimentGenus has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Genus this week, compared to 0 articles on an average week.Search InterestOnly 4 people have searched for GNS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Genus insiders have bought more of their company's stock than they have sold. Specifically, they have bought £54,000 in company stock and sold GBX 0 in company stock.Percentage Held by InsidersOnly 0.61% of the stock of Genus is held by insiders.Percentage Held by Institutions79.99% of the stock of Genus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Genus' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Genus is 3,352.94, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 128.08.Price to Earnings Ratio vs. SectorThe P/E ratio of Genus is 3,352.94, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 114.96.Price to Earnings Growth RatioGenus has a PEG Ratio of 2.87. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGenus has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressEx-CIA Advisor: “This is How Kamala will Rig the Election”A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…Click here now and learn how to prepare. About Genus Stock (LON:GNS)Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.Read More GNS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GNS Stock News HeadlinesSeptember 7 at 1:10 AM | insidertrades.comIain Ferguson Acquires 3,000 Shares of Genus plc (LON:GNS) StockSeptember 7 at 4:39 AM | finance.yahoo.comGenus Full Year 2024 Earnings: EPS Misses ExpectationsSeptember 7, 2024 | Paradigm Press (Ad)Ex-CIA Advisor: “This is How Kamala will Rig the Election”A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…September 5 at 7:52 PM | msn.comIs it time I bought the huge 71% dip on this FTSE 250 growth stock?September 5 at 7:52 PM | markets.businessinsider.comGenus FY24 Profit DownJuly 25, 2024 | finance.yahoo.comCalculating The Intrinsic Value Of Genus plc (LON:GNS)July 20, 2024 | markets.businessinsider.comGenus plc (GNS) Gets a Buy from Kepler CapitalJuly 19, 2024 | msn.comFTSE 100 closes higher as defensive stocks offset inflation jittersSeptember 7, 2024 | Paradigm Press (Ad)Ex-CIA Advisor: “This is How Kamala will Rig the Election”A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…May 7, 2024 | lse.co.ukLondon open: Stocks rally as investors mull retail sales, house pricesMay 3, 2024 | lse.co.ukLondon midday: Stocks extend gains as Anglo rallies; payrolls eyedApril 22, 2024 | finance.yahoo.comWith 83% institutional ownership, Genus plc (LON:GNS) is a favorite amongst the big gunsApril 2, 2024 | msn.comFact Check: Video Claimed Scuba Diver Swam With Dinosaur. Here's the TruthMarch 14, 2024 | msn.comShould I buy the current dogs of the FTSE 250?February 25, 2024 | finance.yahoo.comGenus plc (LON:GNS) Just Reported Earnings, And Analysts Cut Their Target PriceFebruary 22, 2024 | lse.co.ukGenus touts programme to boost investment returns as profit declinesFebruary 22, 2024 | finance.yahoo.comGenus plc Reports Interim Results for the Six Months Ended 31 December 2023February 16, 2024 | finance.yahoo.comEstimating The Intrinsic Value Of Genus plc (LON:GNS)See More Headlines Receive GNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryPersonal Services Current SymbolLON:GNS CUSIPN/A CIKN/A Webwww.genusplc.com Phone+44-1256-347100FaxN/AEmployees480Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 2,150 High Stock Price TargetGBX 2,150 Low Stock Price TargetGBX 2,150 Potential Upside/Downside+25.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.51 Trailing P/E Ratio3,352.94 Forward P/E Ratio22.48 P/E Growth2.87Net Income£33.40 million Net Margins4.96% Pretax MarginN/A Return on Equity5.27% Return on Assets3.18% Debt Debt-to-Equity Ratio50.99 Current Ratio2.15 Quick Ratio1.08 Sales & Book Value Annual Sales£673.10 million Price / Sales1.68 Cash FlowGBX 33.82 per share Price / Cash Flow50.56 Book ValueGBX 875 per share Price / Book1.95Miscellaneous Outstanding Shares66,030,000Free FloatN/AMarket Cap£1.13 billion OptionableNot Optionable Beta0.38 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Jorgen Kokke (Age 56)Chief Executive Officer & Director Comp: $586.74kMs. Alison Jane Henriksen ACA (Age 57)CFO & Executive Director Comp: $605kDr. Matt CulbertsonChief Operating OfficerDr. Elena RiceHead of R&D and Chief Scientific OfficerMr. Daniel William David HartleyGroup General Counsel & Company SecretaryMs. Angelle R. RosataGroup Human Resources DirectorMr. Jerry ThompsonGlobal Head of Beef & AquaAndrew ThompsonHead of ABS EMEAMs. Janet DuaneGroup Financial ControllerMore ExecutivesKey CompetitorsDechra PharmaceuticalsLON:DPHIG GroupLON:IGGCity of LondonLON:CTYWH SmithLON:SMWHKerry GroupLON:KYGAView All CompetitorsInsidersIain FergusonBought 3,000 shares on 9/5/2024Total: £5.40 M ($1,800.00/share)Stephen WilsonSold 5,241 sharesTotal: £11.23 M ($2,142.00/share)View All Insider Transactions GNS Stock Analysis - Frequently Asked Questions How have GNS shares performed this year? Genus' stock was trading at GBX 2,170 at the beginning of the year. Since then, GNS stock has decreased by 21.2% and is now trading at GBX 1,710. View the best growth stocks for 2024 here. How do I buy shares of Genus? Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Genus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco (BATS), Cronos Group (CRON) and Dairy Crest Group (DCG). This page (LON:GNS) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genus plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.